STaR Trial: Multiple Ligament Knee Injuries

NCT03543098 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 690

Last updated 2026-01-29

No results posted yet for this study

Summary

The purpose of this study is to investigate effects of timing of surgery (early vs. delayed) and timing of post-operative rehabilitation (early vs. delayed) for the treatment of military personnel and civilians that sustain a multiple ligament knee injury. To achieve this overall objective of this project, we will conduct two parallel randomized clinical trials. For the first study we will randomize individuals to timing of surgery and timing of post-operative rehabilitation. We hypothesize that early surgery, early rehabilitation and the combination of early surgery with early rehabilitation will lead to an earlier and more complete return to pre-injury military duty, work and sports and better patient-reported physical function. In the second study, those whose timing of surgery can not be randomized, will be only randomized to early or delayed rehabilitation. For this study, we hypothesize that early rehabilitation will lead to an earlier and more complete return to pre-injury military duty, work and sports activity and better patient-reported physical function.

Conditions

  • Knee Dislocations
  • Multiple Ligament Knee Injuries

Interventions

PROCEDURE

Early Surgery

Subjects will undergo surgery within 6 weeks after injury.

PROCEDURE

Delayed Surgery

Subjects will undergo surgery 12 to 16 weeks after injury.

PROCEDURE

Early Rehab

Subjects will undergo rehabilitation that will include unrestricted range of motion exercises and use of a weightbearing as tolerated gait starting after the first post-operative visit with the surgeon.

PROCEDURE

Delayed Rehab

Subjects will undergo rehabilitation that will include use of a knee brace locked in extension, no range of motion exercises and use of non-weightbearing gait for the first 4 weeks after surgery.

Sponsors & Collaborators

  • Rhode Island Hospital

    collaborator OTHER
  • Hospital for Special Surgery, New York

    collaborator OTHER
  • Mayo Clinic

    collaborator OTHER
  • New York University

    collaborator OTHER
  • University of Cincinnati

    collaborator OTHER
  • University of Kentucky

    collaborator OTHER
  • University of Maryland

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • University of Minnesota

    collaborator OTHER
  • University of Missouri-Columbia

    collaborator OTHER
  • University of New Mexico

    collaborator OTHER
  • University of Washington

    collaborator OTHER
  • Washington University School of Medicine

    collaborator OTHER
  • San Antonio Military Medical Center

    collaborator FED
  • Walter Reed National Military Medical Center

    collaborator FED
  • William Beaumont Army Medical Center

    collaborator FED
  • TRIA Orthopaedic Center

    collaborator OTHER
  • Wake Forest University

    collaborator OTHER
  • Unity Health Toronto

    collaborator OTHER
  • Western University, Canada

    collaborator OTHER
  • Ochsner Health System

    collaborator OTHER
  • Yale University

    collaborator OTHER
  • OrthoCarolina Research Institute, Inc.

    collaborator OTHER
  • Louisiana State University Health Sciences Center Shreveport

    collaborator OTHER
  • Duke University

    collaborator OTHER
  • University of Calgary

    collaborator OTHER
  • Oregon Health and Science University

    collaborator OTHER
  • Wake Forest University Health Sciences

    collaborator OTHER
  • Orlando Health, Inc.

    collaborator OTHER
  • Fraser Orthopaedic Institute

    collaborator UNKNOWN
  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • James Irrgang, PT, PhD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03543098 on ClinicalTrials.gov